Murat Araz

584 total citations
62 papers, 341 citations indexed

About

Murat Araz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Murat Araz has authored 62 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Murat Araz's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Murat Araz is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Murat Araz collaborates with scholars based in Türkiye, United States and Somalia. Murat Araz's co-authors include Ümmühan Aktürk, Behice Erci, Mutlu Kartal, Seydi Okumuş, İbrahim Erbağcı, Ersin Akarsu, Mehmet Artaç, Güler Yavaş, Çağdaş Yavaş and Mehmet Zahid Koçak and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Prostate.

In The Last Decade

Murat Araz

41 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murat Araz Türkiye 10 103 102 76 71 53 62 341
Meera M. Dhodapkar United States 9 26 0.3× 88 0.9× 37 0.5× 20 0.3× 131 2.5× 57 393
M. Catherine Brown Canada 14 23 0.2× 213 2.1× 117 1.5× 5 0.1× 91 1.7× 75 549
Fabrizio Presicce Italy 15 35 0.3× 47 0.5× 308 4.1× 108 1.5× 74 1.4× 41 689
Huah Shin Ng Australia 14 167 1.6× 162 1.6× 65 0.9× 20 0.3× 16 0.3× 36 548
Kamnesh R. Pradhan United States 12 70 0.7× 227 2.2× 110 1.4× 16 0.2× 30 0.6× 22 566
Farid Arman United States 10 52 0.5× 40 0.4× 80 1.1× 29 0.4× 34 0.6× 33 329
María Fasero Spain 12 39 0.4× 85 0.8× 31 0.4× 68 1.0× 72 1.4× 44 419
Charles Stava United States 12 20 0.2× 370 3.6× 118 1.6× 90 1.3× 63 1.2× 17 605
Leena R. Baghdadi Saudi Arabia 10 32 0.3× 21 0.2× 20 0.3× 19 0.3× 30 0.6× 21 392
Tsuyoshi Yamashita Japan 10 26 0.3× 36 0.4× 39 0.5× 63 0.9× 133 2.5× 22 594

Countries citing papers authored by Murat Araz

Since Specialization
Citations

This map shows the geographic impact of Murat Araz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murat Araz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murat Araz more than expected).

Fields of papers citing papers by Murat Araz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murat Araz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murat Araz. The network helps show where Murat Araz may publish in the future.

Co-authorship network of co-authors of Murat Araz

This figure shows the co-authorship network connecting the top 25 collaborators of Murat Araz. A scholar is included among the top collaborators of Murat Araz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murat Araz. Murat Araz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Araz, Murat, et al.. (2025). Small cell lung cancer differentiation in patients with driver mutant non-small cell lung cancer: a single center experience. Journal of Cancer Research and Clinical Oncology. 151(7). 199–199.
3.
4.
Araz, Murat, et al.. (2024). Gemcitabine-related fatal cholestatic hepatitis. Oncology in Clinical Practice. 21(2). 166–171. 1 indexed citations
5.
Demir, Tarık, Murat Araz, Mehmet Zahid Koçak, et al.. (2024). Efficacy of systemic treatments in patients with metastatic lung invasive mucinous adenocarcinoma.. Journal of Clinical Oncology. 42(16_suppl). e20609–e20609.
6.
Araz, Murat, et al.. (2024). Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report. Journal of Oncology Pharmacy Practice. 31(1). 160–163.
7.
Araz, Murat, et al.. (2024). Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer. Journal of Oncology Pharmacy Practice. 31(1). 168–171.
8.
9.
Araz, Murat, et al.. (2024). Metastatic prostate adenocarcinoma presenting with ptosis due to sphenoid sinus metastasis — a rare case report. SHILAP Revista de lepidopterología. 21(6). 460–465.
10.
Koçak, Mehmet Zahid, et al.. (2023). The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study. Journal of Cancer Research and Clinical Oncology. 149(11). 9183–9189. 2 indexed citations
11.
12.
Karaağaç, Mustafa, et al.. (2022). Prognostic Significance of Adipose Tissue Distribution and Metabolic Activity in PET/CT in Patients with Metastatic Colorectal Cancer. Journal of Gastrointestinal Cancer. 54(2). 456–466. 2 indexed citations
13.
Geredeli, Çağlayan, et al.. (2022). The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer. European Journal of Clinical Pharmacology. 79(2). 243–248. 13 indexed citations
14.
Araz, Murat, et al.. (2020). Bir Üniversite Hastanesi İç Hastalıkları Kliniği Tarafından Bakılan Konsültasyonların Değerlendirilmesi. Online Türk Sağlık Bilimleri Dergisi. 5(1). 71–80.
15.
Demir, Tarık, Murat Araz, Osman Köstek, et al.. (2020). Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?. Current Problems in Cancer. 45(1). 100619–100619. 4 indexed citations
16.
Araz, Murat, et al.. (2018). Are preoperative serum CA15-3 levels different in breast cancer subgroups?. Current Problems in Cancer. 43(2). 115–122. 9 indexed citations
17.
Araz, Murat, et al.. (2018). The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group. Current Problems in Cancer. 43(4). 344–353. 2 indexed citations
18.
Aktürk, Ümmühan, Behice Erci, & Murat Araz. (2017). Functional evaluation of treatment of chronic disease: Validity and reliability of the Turkish version of the Spiritual Well-Being Scale. Palliative & Supportive Care. 15(6). 684–692. 56 indexed citations
19.
Yavaş, Güler, et al.. (2012). HER-2 positive primary solid neuroendocrine carcinoma of the breast: a case report and review of the literature. Breast Cancer. 22(4). 432–436. 9 indexed citations
20.
Akarsu, Ersin, et al.. (2006). Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves’ ophthalmopathy. International Journal of Clinical Practice. 61(1). 45–51. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meera M. Dhodapkar Breakdown of academic impact, for papers by M. Catherine Brown Breakdown of academic impact, for papers by Fabrizio Presicce Breakdown of academic impact, for papers by Huah Shin Ng Breakdown of academic impact, for papers by Kamnesh R. Pradhan Breakdown of academic impact, for papers by Farid Arman Breakdown of academic impact, for papers by María Fasero Breakdown of academic impact, for papers by Charles Stava Breakdown of academic impact, for papers by Leena R. Baghdadi Breakdown of academic impact, for papers by Tsuyoshi Yamashita
Rankless by CCL
2026